Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q2 2014 · 10-Q
Revenue$5.06B$5.06B+2.5% vs Q2 2013 Net Income$466.00M$466.00M−2.1% vs Q2 2013 EPS Diluted$0.30$0.30±0.0% vs Q2 2013 Gross Profit$2,636,000,000+8.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$900,000,000+25.5% Free Cash Flowderived$642,000,000+50.7% Margins · derivedGross margin52.1%+2.9 pt vs Q2 2013
Operating margin13.4%+0.7 pt vs Q2 2013
Net margin9.2%−0.4 pt vs Q2 2013
ended Jun 30, 2014 · filed Aug 5, 2014 · 36 d after period end